194 related articles for article (PubMed ID: 21995575)
41. Immunotherapy in the context of hematopoietic stem cell transplantation: the emerging role of natural killer cells and mesenchymal stromal cells.
Lankester AC; Ball LM; Lang P; Handgretinger R
Pediatr Clin North Am; 2010 Feb; 57(1):97-121. PubMed ID: 20307714
[TBL] [Abstract][Full Text] [Related]
42. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
Peggs KS; Quezada SA; Allison JP
Immunol Rev; 2008 Aug; 224():141-65. PubMed ID: 18759925
[TBL] [Abstract][Full Text] [Related]
43. Pathophysiology of tumor-associated macrophages.
Yuan A; Chen JJ; Yang PC
Adv Clin Chem; 2008; 45():199-223. PubMed ID: 18429498
[TBL] [Abstract][Full Text] [Related]
44. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
[TBL] [Abstract][Full Text] [Related]
45. Cytotoxic lymphocytes: redirecting the cell-mediated immune response for the therapy of cancer.
Kershaw MH; Trapani JA; Smyth MJ
Ther Immunol; 1995 Jun; 2(3):173-81. PubMed ID: 8885135
[TBL] [Abstract][Full Text] [Related]
46. Stromal cell networks coordinate immune response generation and maintenance.
Alexandre YO; Mueller SN
Immunol Rev; 2018 May; 283(1):77-85. PubMed ID: 29664562
[TBL] [Abstract][Full Text] [Related]
47. The role of tumor stroma in the interaction between tumor and immune system.
Blankenstein T
Curr Opin Immunol; 2005 Apr; 17(2):180-6. PubMed ID: 15766679
[TBL] [Abstract][Full Text] [Related]
48. Estrogen suppresses stromal cell-dependent lymphopoiesis in culture.
Smithson G; Medina K; Ponting I; Kincade PW
J Immunol; 1995 Oct; 155(7):3409-17. PubMed ID: 7561035
[TBL] [Abstract][Full Text] [Related]
49. Immune-suppressive properties of the tumor microenvironment.
Becker JC; Andersen MH; Schrama D; Thor Straten P
Cancer Immunol Immunother; 2013 Jul; 62(7):1137-48. PubMed ID: 23666510
[TBL] [Abstract][Full Text] [Related]
50. Changing the tumor microenvironment: new strategies for immunotherapy.
Berraondo P; Umansky V; Melero I
Cancer Res; 2012 Oct; 72(20):5159-64. PubMed ID: 22826606
[TBL] [Abstract][Full Text] [Related]
51. The tumor microenvironment.
Weber CE; Kuo PC
Surg Oncol; 2012 Sep; 21(3):172-7. PubMed ID: 21963199
[TBL] [Abstract][Full Text] [Related]
52. [Role of the stroma in the initiation and progression of tumors].
Baranyi M; Lippai M; Szatmári Z
Orv Hetil; 2015 Nov; 156(45):1816-23. PubMed ID: 26522855
[TBL] [Abstract][Full Text] [Related]
53. Immunological hallmarks of stromal cells in the tumour microenvironment.
Turley SJ; Cremasco V; Astarita JL
Nat Rev Immunol; 2015 Nov; 15(11):669-82. PubMed ID: 26471778
[TBL] [Abstract][Full Text] [Related]
54. Tumor microenvironment and the role of mesenchymal stromal cells.
Kucerova L; Skolekova S
Neoplasma; 2013; 60(1):1-10. PubMed ID: 23067210
[TBL] [Abstract][Full Text] [Related]
55. T cell exclusion, immune privilege, and the tumor microenvironment.
Joyce JA; Fearon DT
Science; 2015 Apr; 348(6230):74-80. PubMed ID: 25838376
[TBL] [Abstract][Full Text] [Related]
56. Therapeutic targeting of tumor-stroma interactions.
Hiscox S; Barrett-Lee P; Nicholson RI
Expert Opin Ther Targets; 2011 May; 15(5):609-21. PubMed ID: 21388336
[TBL] [Abstract][Full Text] [Related]
57. Tertiary lymphoid tissue in the tumor microenvironment: from its occurrence to immunotherapeutic implications.
Di Caro G; Castino GF; Bergomas F; Cortese N; Chiriva-Internati M; Grizzi F; Mantovani A; Marchesi F
Int Rev Immunol; 2015 Mar; 34(2):123-33. PubMed ID: 25901857
[TBL] [Abstract][Full Text] [Related]
58. Regulatory circuits of T cell function in cancer.
Speiser DE; Ho PC; Verdeil G
Nat Rev Immunol; 2016 Oct; 16(10):599-611. PubMed ID: 27526640
[TBL] [Abstract][Full Text] [Related]
59. Emerging roles of the tumor-associated stroma in promoting tumor metastasis.
Horimoto Y; Polanska UM; Takahashi Y; Orimo A
Cell Adh Migr; 2012; 6(3):193-202. PubMed ID: 22568980
[TBL] [Abstract][Full Text] [Related]
60. Tissue-Dependent Tumor Microenvironments and Their Impact on Immunotherapy Responses.
Oliver AJ; Lau PKH; Unsworth AS; Loi S; Darcy PK; Kershaw MH; Slaney CY
Front Immunol; 2018; 9():70. PubMed ID: 29445373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
